Coherence for Health
Hide / Show Abstract

Coherence for Health

Innovation for New Medicines for Infectious Diseases

In developing countries, 6 out of 10 people die from infectious diseases. Nearly 1 billion humans suffer from a neglected infectious disease, according to the World Health Organisation. Yet less than 1% of the new drugs placed on the market from 1975 to the turn of the century were developed for these diseases. This book looks at ways of improving the availability of medicines for infectious diseases through strengthened coherence in health, trade, science and technology, development co-operation and finance.
Click to Access: 
    http://oecd.metastore.ingenta.com/content/0309051e.pdf
  • PDF
  • http://www.keepeek.com/Digital-Asset-Management/oecd/development/coherence-for-health_9789264060166-en
  • READ
 
Chapter
 

Annex C

OECD Country Policy Options for Increasing the Availability of Medicines for Neglected Diseases You do not have access to this content

English
Click to Access: 
    http://oecd.metastore.ingenta.com/content/0309051ec009.pdf
  • PDF
  • http://www.keepeek.com/Digital-Asset-Management/oecd/development/coherence-for-health/annex-c_9789264060166-9-en
  • READ
Author(s):
Michael Kremer, Heidi Williams

Hide / Show Abstract

Together, malaria, tuberculosis, and the strains of HIV common in Africa kill 5 million people each year, almost all of them in poor countries. Yet research and development (R&D) on health technologies for these and other diseases concentrated in poor countries remains minimal.
 
Visit the OECD web site